🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main reason for this study is to see if Acthar Gel can reduce inflammat...
Status
Terminated
Location
Blue Ocean Clinical Research
Start Date
2018-10-05
Trial ID
NCT03656692
Treatments Being Tested
IgA nephropathy occurs when IgA-a protein that helps the body fight infecti...
Status
Withdrawn
Location
Harris Health System Smith Clinic or Ben Taub Hospital
Start Date
2015-02
Trial ID
NCT02382523
Treatments Being Tested
This is an open label safety and feasibility trial using Acthar® in additio...
Status
Withdrawn
Location
University of North Carolina at Chapel Hill
Start Date
2021-03
Trial ID
NCT02399462
Treatments Being Tested
Membranous Nephropathy (MN) is an immune-mediated kidney disease that affec...
Status
Completed
Location
University Health Network- Toronto General Hospital
Start Date
2010-02
Trial ID
NCT01093157
Treatments Being Tested
This is a 2-part study to examine the effect of Acthar Gel in adult partici...
Status
Completed
Location
East Bay Rheumatology Medical Group
Start Date
2016-11-07
Trial ID
NCT02919761
Treatments Being Tested
The purpose of this study is to evaluate whether the use of ACTH in additio...
Status
Withdrawn
Location
University at Buffalo, Buffalo General Hospital
Start Date
2009-12
Trial ID
NCT00986960
Treatments Being Tested
We hypothesize that corticotropin or adrenocorticotrophic hormone (ACTH), a...
Status
Completed
Location
USC MS Center
Start Date
2009-11
Trial ID
NCT01049451
Treatments Being Tested
The purpose of this pilot study is to assess repository corticotropin injec...
Status
Withdrawn
Location
University of Alabama at Birmingham
Start Date
2018-11-01
Trial ID
NCT03398018
Treatments Being Tested
This pilot study is aimed at demonstrating the effectiveness of ACTH (H.P. ...
Status
Completed
Location
Mayo Clinic
Start Date
2009-01
Trial ID
NCT00805753
Treatments Being Tested
Tolerability of Acthar for the Treatment of Multiple Sclerosis Relapses (TA...
Status
Completed
Location
OhioHealth
Start Date
2014-06
Trial ID
NCT02258217
Treatments Being Tested